Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
0.7620
-0.0270 (-3.42%)
At close: Aug 1, 2025, 4:00 PM
0.7500
-0.0120 (-1.57%)
After-hours: Aug 1, 2025, 7:54 PM EDT
Predictive Oncology Employees
As of December 31, 2024, Predictive Oncology had 24 total employees, including 23 full-time and 1 part-time employees. The number of employees decreased by 11 or -31.43% compared to the previous year.
Employees
24
Change (1Y)
-11
Growth (1Y)
-31.43%
Revenue / Employee
$72,053
Profits / Employee
-$453,684
Market Cap
7.33M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 24 | -11 | -31.43% |
Dec 31, 2023 | 35 | 1 | 2.94% |
Dec 31, 2022 | 34 | 2 | 6.25% |
Dec 31, 2021 | 32 | 9 | 39.13% |
Dec 31, 2020 | 23 | -9 | -28.13% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
POAI News
- 25 days ago - Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing - GlobeNewsWire
- 7 weeks ago - Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - GlobeNewsWire
- 2 months ago - Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewsWire
- 2 months ago - AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - GlobeNewsWire
- 2 months ago - Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" - GlobeNewsWire
- 2 months ago - Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - GlobeNewsWire